Tema ETFs’s Voyager Therapeutics VYGR Stock Holding History

Tema ETFs’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,960	Closed	-$46.5K	–	529
2025 Q2	$46.5K	Hold	14,960	–	–	0.01%	165
2025 Q1	$50.6K	Hold	14,960	–	–	0.02%	147
2024 Q4	$84.8K	Buy	+14,960	New	+$96.4K	0.04%	146

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tema ETFs's VYGR Position: Q3 2025 in Review

Tema ETFs sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 14,960 shares — an estimated $46.5K sold.

Tema ETFs first reported a position in VYGR in Q4 2024 and held it in 3 quarters. The position peaked at $84.8K in Q4 2024. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

Tema ETFs reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
Tema ETFs sold 14,960 Voyager Therapeutics shares in Q3 2025, an estimated $46.5K.
Tema ETFs first reported a position in Voyager Therapeutics in Q4 2024 and held it in 3 quarters.
Tema ETFs's Voyager Therapeutics position peaked at $84.8K in Q4 2024.
117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Tema ETFs's 13F filing for Q3 2025, filed 24 Oct 2025.